Fosfor tak hanya mendukung kesejahteraan tulang ibu, tetapi juga janin. Maka dari itu, penting sekali untuk memenuhi ...

Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...

Following our analysis of the options activities associated with Ultragenyx Pharmaceutical, we pivot to a closer look at the company's own performance. With a volume of 9,702,498, the price of RARE is ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $64.75, a high estimate of $65.00, and a low estimate of $64.00. This current ...

Researchers sought to determine whether adding elotuzumab to PVd would be safe and effective in treating patients with relapsed or refractory MM.

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA®</ ...

Last year, five possible cases of X-Linked Hypophosphatemia (XLH) were identified via MendelScan technology and all of these cases were moved forward by clinical reviewers.

INTRODUCTION X-linked hypophosphatemia (XLH) is a lifelong condition associated with decreased serum phosphate levels and clinically characterized by rickets in children and osteomalacia in adults ( 1 ...

Two River Theater has appointed three new Board Members highlighting a distinguished and versatile group of individuals. Learn more about the company changes here!